Scynexis (SCYX) Total Current Liabilities (2013 - 2026)
Scynexis' (SCYX) quarterly Total Current Liabilities came in at $15.9 million in Q1 2026, up 77.51% YoY from $9.0 million in Q1 2025, and up 177.29% on a QoQ basis from $5.7 million in Q4 2025.
Scynexis (SCYX) Total Current Liabilities (2013 - 2026) Analysis & Trends
Scynexis (SCYX) has 14 years of Total Current Liabilities data on file, last reported at $15.9 million in Q1 2026.
- Quarterly Total Current Liabilities rose 77.51% year-over-year to $15.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.9 million (up 77.51% YoY) and the FY2025 annual result came in at $5.7 million, down 76.21% from the prior year.
- Total Current Liabilities rose to $15.9 million in Q1 2026, from $5.7 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $45.6 million in Q1 2023 to a low of $5.7 million in Q4 2025.
- A 5-year average of $18.1 million and a median of $16.2 million in 2023 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2023 — Total Current Liabilities surged 252.63% — and 2025, when it tumbled 76.21%.
- Tracing SCYX's Total Current Liabilities over 5 years: stood at $17.6 million in 2022, then declined by 7.46% to $16.3 million in 2023, then jumped by 47.82% to $24.1 million in 2024, then plunged by 76.21% to $5.7 million in 2025, then surged by 177.29% to $15.9 million in 2026.
- The last three Total Current Liabilities figures came in at $15.9 million (Q1 2026), $5.7 million (Q4 2025), and $8.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 1.79 Bn |
| 10 | Scynexis | 62.02 Mn | -52.68 Mn | - | 5.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.83 Mn |
| Mar 31, 2026 | 15.90 Mn |
| Dec 31, 2025 | 5.73 Mn |
| Sep 30, 2025 | 8.47 Mn |
| Jun 30, 2025 | 10.86 Mn |
| Mar 31, 2025 | 8.96 Mn |
| Dec 31, 2024 | 24.10 Mn |
| Sep 30, 2024 | 25.72 Mn |
| Jun 30, 2024 | 25.23 Mn |
| Mar 31, 2024 | 27.35 Mn |
| Dec 31, 2023 | 16.30 Mn |
| Sep 30, 2023 | 16.79 Mn |
| Jun 30, 2023 | 16.16 Mn |
| Mar 31, 2023 | 45.64 Mn |
| Dec 31, 2022 | 17.62 Mn |
| Sep 30, 2022 | 14.26 Mn |
| Jun 30, 2022 | 16.01 Mn |
| Mar 31, 2022 | 12.94 Mn |
| Dec 31, 2021 | 13.62 Mn |
| Sep 30, 2021 | 13.22 Mn |